FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c.
about
FOXM1: an emerging master regulator of DNA damage response and genotoxic agent resistanceSUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cellsActivation of AMPK inhibits cervical cancer cell growth through AKT/FOXO3a/FOXM1 signaling cascadeSystematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapyFarnesoid X receptor, the bile acid sensing nuclear receptor, in liver regeneration.Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.HGF/Met and FOXM1 form a positive feedback loop and render pancreatic cancer cells resistance to Met inhibition and aggressive phenotypes.Splicing imbalances in basal-like breast cancer underpin perturbation of cell surface and oncogenic pathways and are associated with patients' survivalDLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.FOXM1 binds directly to non-consensus sequences in the human genome.FOXM1 predicts overall and disease specific survival in muscle-invasive urothelial carcinoma and presents a differential expression between bladder cancer subtypesForkhead box transcription factors in cancer initiation, progression and chemotherapeutic drug response.Targeting Forkhead Box M1 Transcription Factor in Breast Cancer.
P2860
Q26864654-923F9B75-D320-455D-8804-FC574344E13DQ33907729-DCB4D08D-E6BF-49D6-B625-8544E40D531DQ34789931-D83CA1EC-F931-4FC6-B1DD-F2E30257DC6BQ35740435-5D28006E-0836-4AD9-BA5F-4F9BCFEC5E2FQ36237921-BCEFEAE4-8DB5-4EE1-92B5-AC643BAA173EQ36413849-49992679-DBCC-4B8E-A65C-DFA37F145160Q37086095-20AA5B38-46F7-4081-A81E-E6472B385989Q37176592-29EB4274-6ABE-4EC1-9420-E7E149BBF77CQ37563571-02E6E873-9334-4E43-BB21-3AFB50CC1B55Q37697488-39B32436-DEA6-4842-A299-59EE3E4AE1B9Q38861035-C506A874-7850-43B5-A794-03B6C1768E42Q41471202-CEC9EE0F-1AE0-4681-9E16-1906049074F8Q42966267-5A0FAADA-DC8A-4180-8438-93532D850963Q54977309-9A535EBF-6065-4D31-B8E3-A5E2096F3C1A
P2860
FOXM1b, which is present at elevated levels in cancer cells, has a greater transforming potential than FOXM1c.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
FOXM1b, which is present at el ...... forming potential than FOXM1c.
@ast
FOXM1b, which is present at el ...... forming potential than FOXM1c.
@en
type
label
FOXM1b, which is present at el ...... forming potential than FOXM1c.
@ast
FOXM1b, which is present at el ...... forming potential than FOXM1c.
@en
prefLabel
FOXM1b, which is present at el ...... forming potential than FOXM1c.
@ast
FOXM1b, which is present at el ...... forming potential than FOXM1c.
@en
P2093
P2860
P356
P1476
FOXM1b, which is present at el ...... sforming potential than FOXM1c
@en
P2093
Adaline W L Ngan
Andy K Y Lam
Davis C T Kwok
Kwok-Ming Yao
Man-Hong Leung
Vincent W S Liu
Wai Y Leung
P2860
P356
10.3389/FONC.2013.00011
P50
P577
2013-01-31T00:00:00Z